• News
  • Investors
  • Careers
  • Contact
  • X
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Clinical Trials
    • Expanded Access Policy
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Urea Cycle Disorders
    • Vascular Ehlers-Danlos
  • Products
    • MIPLYFFA ®
    • OLPRUVA ®
    • AZSTARYS ®
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Quote & Chart
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • [email protected]
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home
  • Menu Menu

About Us

We are a nimble rare disease therapeutics company with a proven record of bringing new therapies to patients.

Bringing life-changing therapeutics to people living with rare diseases

Vision Statement

To give every promising rare disease therapy candidate a fighting chance to reach patients and improve their quality of life.

Who We Are

We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners and advocacy groups in all of our clinical and regulatory development strategies.

With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients.

Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.

About Zevra Therapeutics

Nimble and determined, Zevra pushes boundaries beyond what is possible to advance new therapies that meaningfully improve patients’ lives.

The Zevra Story

Our Name

Zevra is Greek for zebra, the official symbol of rare disease. The idea came from the medical school adage, “when you hear hoofbeats, don’t expect a zebra,” meaning, illness is most likely caused by something common, not rare.

However, in a world of horses, we are paying attention to the zebras, people with rare diseases. In honor of our commitment, we named our company for them.

The distinct stripes of an individual zebra symbolize the many rare diseases represented by these patient communities.

To us, like the infinite, unique possibilities of a zebra’s stripes, we believe there are boundless pathways for therapeutics to achieve regulatory approval and reach people with rare diseases.

Neil F. McFarlane

November 24, 2024
President & Chief Executive Officer
https://zevra.com/wp-content/uploads/Zevra_Headshots-Neil.png 429 319 David Anderson /wp-content/uploads/logo.svg David Anderson2024-11-24 12:08:342024-11-25 07:55:09Neil F. McFarlane

R. LaDuane Clifton, MBA, CPA

November 23, 2024
Chief Financial Officer, Secretary, & Treasurer
https://zevra.com/wp-content/uploads/Zevra_Headshots-LeDuane.png 429 320 eallison /wp-content/uploads/logo.svg eallison2024-11-23 12:52:422024-12-26 08:35:03R. LaDuane Clifton, MBA, CPA

Joshua Schafer

November 22, 2024
Chief Commercial Officer
https://zevra.com/wp-content/uploads/Zevra_Headshots-Josh.png 428 319 David Anderson /wp-content/uploads/logo.svg David Anderson2024-11-22 13:38:522025-03-31 19:05:48Joshua Schafer

Adrian Quartel, M.D., FFPM

November 21, 2024
Chief Medical Officer
https://zevra.com/wp-content/uploads/Zevra_Headshots-Adrian.jpg 428 320 David Anderson /wp-content/uploads/logo.svg David Anderson2024-11-21 15:47:202024-11-25 07:56:31Adrian Quartel, M.D., FFPM

Rahsaan W. Thompson

November 18, 2024
Chief Legal Officer, Secretary and Compliance Officer
https://zevra.com/wp-content/uploads/Rahsaan-pic.jpg 688 523 Jeff Lorber /wp-content/uploads/logo.svg Jeff Lorber2024-11-18 09:36:222024-11-25 07:57:31Rahsaan W. Thompson

Alison Peters

November 17, 2024
Chief People Officer
https://zevra.com/wp-content/uploads/Alison-Peters.jpg 1184 900 Jeff Lorber /wp-content/uploads/logo.svg Jeff Lorber2024-11-17 09:34:422024-11-25 07:57:40Alison Peters

Tanya Hayden

November 17, 2024
Senior Vice President, Chief of Staff
https://zevra.com/wp-content/uploads/Tanya-pic.jpg 1184 900 Jeff Lorber /wp-content/uploads/logo.svg Jeff Lorber2024-11-17 01:20:222024-12-16 13:08:35Tanya Hayden

Gerald Orehostky

November 12, 2024
Senior Vice President, Regulatory Affairs and Quality
https://zevra.com/wp-content/uploads/jerry-headshot-1.jpg 688 523 Jeff Lorber /wp-content/uploads/logo.svg Jeff Lorber2024-11-12 08:33:342024-11-25 07:58:16Gerald Orehostky

Christopher M. Lauderback, PhD

November 10, 2024
Senior Vice President, Manufacturing
https://zevra.com/wp-content/uploads/Zevra_Headshots-Christopher.png 428 319 eallison /wp-content/uploads/logo.svg eallison2024-11-10 12:54:022024-11-25 07:58:29Christopher M. Lauderback, PhD

Timothy Sangiovanni, CPA

November 8, 2024
Senior Vice President, Corporate Controller
https://zevra.com/wp-content/uploads/Zevra_Headshots-Timothy.png 428 319 eallison /wp-content/uploads/logo.svg eallison2024-11-08 12:54:392024-11-25 07:58:45Timothy Sangiovanni, CPA

Board of Directors

Alvin Shih, M.D.

January 23, 2024/in BOD/by David Anderson

Compensation Committee, Nominating and Corporate Governance Committee

Read more
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2024-01-23 04:48:592024-04-08 18:45:58Alvin Shih, M.D.

Neil F. McFarlane

October 9, 2023/in BOD/by David Anderson

Board Member

Read more
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-10-09 12:05:382024-07-29 09:58:59Neil F. McFarlane

Thomas D. Anderson

August 4, 2023/in BOD/by David Anderson

Compensation Committee Chair, Nominating and Corporate Governance Committee

Read more
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-08-04 12:06:062024-04-08 18:43:18Thomas D. Anderson

Wendy Dixon, Ph.D.

April 26, 2023/in BOD/by David Anderson

Audit Committee

Read more
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-26 12:20:592024-04-08 18:43:59Wendy Dixon, Ph.D.

John B. Bode

April 25, 2023/in BOD/by David Anderson

Audit Committee, Nominating and Corporate Governance Committee Chair

Read more
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-25 17:42:592024-04-08 20:50:30John B. Bode

Douglas W. Calder

April 25, 2023/in BOD/by David Anderson

Compensation Committee

Read more
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-25 17:40:342024-10-28 15:39:37Douglas W. Calder

Corey Watton

April 25, 2023/in BOD/by David Anderson

Audit Committee, Compensation Committee

Read more
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-25 17:39:192024-04-08 18:44:20Corey Watton

Tamara A. (Seymour) Favorito

December 29, 2022/in BOD/by eallison

Audit Committee Chair

Read more
/wp-content/uploads/logo.svg 0 0 eallison /wp-content/uploads/logo.svg eallison2022-12-29 12:55:412024-11-25 07:53:50Tamara A. (Seymour) Favorito
  • X
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Clinical Trials
    • Expanded Access Policy
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Urea Cycle Disorders
    • Vascular Ehlers-Danlos
  • Products
    • MIPLYFFA ®
    • OLPRUVA ®
    • AZSTARYS ®
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Quote & Chart
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • [email protected]
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home

© 2025 Zevra Therapeutics. All rights reserved. | Privacy Policy | Terms of Use

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlySettings

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsHide notification only
Open Message Bar